title: Thrombolytic therapy in acute pulmonary embolism due to heparin-induced thrombocytopenia type II.
abstract: Hospitalized patients are in danger of deep venous thrombosis either due to a genetic tendency, immobilization or the underlying medical condition. Paradoxically heparin, the substance used to prevent this complication, can lead to thrombo-embolic phenomena, which can be life threatening. We report a case of heparin-induced thrombocytopenia, which caused a massive pulmonary embolism, and its management by administering a thrombolytic agent in a situation where bleeding seems inevitable.
authors.affiliation: Department of Cardiology, Riyadh Medical Complex, Ministry of Health, Kingdom of Saudi Arabia. alafifiazza@hotmail.com
authors.forename: Azza A
authors.initials: AA
authors.lastname: Alafify
authors.forename: Tarig S
authors.initials: TS
authors.lastname: Al-Khuwaitir
authors.forename: Abdurahman M
authors.initials: AM
authors.lastname: Al-Mugheiri
authors.forename: Djibril M
authors.initials: DM
authors.lastname: Ndao
mesh_terms: D000063:Accidents, Traffic; D000208:Acute Disease; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009104:Multiple Trauma / Q000175:diagnosis / Q000628:therapy; D049268:Positron-Emission Tomography; D011655:Pulmonary Embolism / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D018570:Risk Assessment; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000379:methods; D016896:Treatment Outcome
chemical_list: D006495:Heparin, Low-Molecular-Weight